Search Results 821-830 of 16964 for monoclonal antibody

  1. A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab - Mayo Clinic

    ... antibody, avelumab, in selected advanced solid tumors. ... Known prior severe hypersensitivity reaction to monoclonal antibodies (grade ≥ 3 by NCI CTCAE v4.

  2. A Dose Escalation Study of HFB301001 in Adult Patients with Advanced Solid Tumors - Mayo Clinic

    composition to monoclonal antibodies or any excipient of HFB301001; - Known active malignancy, with the exception of the specific cancer under investigation

  3. High blood protein When to see a doctor - Mayo Clinic

    https://www.niddk.nih.gov/health-information/kidney-disease/amyloidosis. Accessed Sept. 16, 2024. Monoclonal gammopathy of undetermined significance (MGUS).

  4. A Study of the Structural Parts of Bone in Related Diseases that Have Increased Risk of Fractures - Mayo Clinic

    ... monoclonal gammopathies (related diseases in which patients have an increased risk of fracture). Participation eligibility. Participant eligibility includes ...

  5. Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia - Mayo Clinic

    Chemotherapy < 21 days prior to first administration of study treatment and/or monoclonal antibody < 6 weeks prior to first administration of study treatment.

  6. Immune globulin and hyaluronidase (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Immune globulin and recombinant human hyaluronidase injection contains antibodies that make your immune system stronger. It is used for patients who have ...

  7. Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation - Mayo Clinic

    ... monoclonal antibodies) prior to the index hospital admission. Previous administration of S aureus vaccine or S aureus/Candida vaccine. Antibiotic therapy ...

  8. Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) - Mayo Clinic

    Prior anti-cancer monoclonal antibody (mAb) within 4 weeks prior to study Day 1 or not recovered from an adverse event caused by mAbs administered more than 4 ...

  9. A Study of SC‑004 in Subjects With Advanced Solid Tumors - Mayo Clinic

    Chemotherapy, small molecule inhibitors, radiation, and/or other investigational anticancer agents (excluding investigational monoclonal antibodies): within 2 ...

  10. A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 Tablets - Mayo Clinic

    therapy, including a proteasome inhibitors (PI), an Immunomodulatory drugs (IMID), and an anti-CD38 monoclonal antibody. - Permitted to be venetoclax or BCL ...